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Copyright © 2009 AHC In situ polymerase chain reaction (in situ PCR), which can detect a few copies of genes
within a cell by amplifying the target gene, was developed to better understand the biological
functions of tissues. In this study, we optimized the protocol conditions for the detection of
X chromosome-linked phosphoglycerate kinase-1 (pgk-1) gene in paraffin-embedded sections
of mouse reproductive organs. The effects of various concentrations of proteinase K (PK)
and PCR cycle numbers were examined. To label the amplified DNA, we used digoxigenin-
dUTP (Dig), Cy-3-dUTP (Cy-3), or FluorX-dCTP (FluorX). The optimal concentration of PK
was 50 µg/ml for the ovary and 10 µg/ml for the testis. Ten PCR cycles were optimal for Dig
and 25 cycles were optimal for FluorX and Cy-3 in the ovary and testis. The signal-to-noise
ratio of FluorX and Cy-3 for ovarian tissue was better than that of Dig. Using the above
conditions, we detected 1–4 and 1–2 spots of pgk-1 in the nuclei of granulosa and germ
cells, respectively. Our results indicate that in situ PCR is useful for detecting a specific gene
in paraffin-embedded sections under optimized conditions of both PCR cycle number and
PK concentration.
Key words: in situ PCR, pgk-1, ovary, testis, proteinase K
I. Introduction
The polymerase chain reaction (PCR) method is suit-
able for detection of a few copies of a particular gene based
on its extremely high sensitivity. In fact, the PCR method
allows amplification of a single gene copy in a solution up
a large quantity sufficient for detection by conventional
gel electrophoresis and Southern blot hybridization [16].
However, the PCR method itself cannot detect the site of a
target gene at the cellular level. On the other hand, in situ
hybridization (ISH) is considered a powerful technique for
localization of specific nucleic acid sequences at the level of
individual cells with excellent detection specificity [7–10].
However, the detection sensitivity of ISH is sometimes
limited. The combination of these two methods, called in
situ PCR, first described by Haase et al. in 1990 [6], is an
extremely highly sensitive technique to localize a single
gene copy at the individual cell level [1–4, 11–13, 20, 22].
However, in situ PCR has not gained wide acceptance by
the scientific community, partly because of the significant
variations in the optimal conditions of the protocol, which
depend on the tissues used for analysis [11, 12].
In the present study, we optimized the in situ PCR
protocol for paraffin-embedded sections of the mouse
reproductive organs using X chromosome-linked phospho-
glycerate kinase-1 (pgk-1) gene. Pgk-1 gene within the X
chromosome is ubiquitously expressed in the euchromatic XHishikawa et al. 16
chromosome and is also used as a marker for detection of
mouse sex chimeras [17, 24]. In this study, pgk-1 gene
expression was analyzed in several applications as follows:
(1) the effects of various concentrations of proteinase K
(PK), (2) the amplification of PCR cycles, and (3) visualiza-
tion dyes using digoxigenin-11-dUTP (Dig), Cy-3-dUTP
(Cy-3), and FluorX-10-dCTP (FluorX). After optimization
of these applications, in situ PCR was found to be excellent
for detection of a specific gene in paraffin-embedded tissue
sections.
II. Materials and Methods
Chemicals and biochemicals
Paraformaldehyde (PFA) was purchased from Merck
(Darmstadt, Germany). PK was from Wako Pure Chemi-
cals (Osaka, Japan). Dig was from Roche Diagnostics
(Mannheim, Germany). Cy-3 and FluorX were from
Amersham Biosciences Corp. (Piscataway, NJ). TaKaRa Ex
Taq (Taq DNA polymerase, dNTP mixture, 10×PCR buffer,
and MgCl2) was from Takara Bio Inc. (Shiga, Japan). 3,3'-
diaminobenzidine-4HCl (DAB) was from Dojin Chemical
Co. (Kumamoto, Japan). All other reagents used in this
study were from Wako Pure Chemicals or Sigma Chemical
Co. (St. Louis, MO) and were of analytical grade.
Animals and tissue preparation
The study was conducted in 6- to 8-week-old ICR mice.
All experiments were conducted according to the principles
and procedures outlined in the Guidelines for Animal
Experimentation of Nagasaki University with the approval
of the Institutional Animal Care and Use Committee. For
tissue sampling, the ovaries and testes were harvested
under ether anesthesia. They were cut into small pieces and
divided into two groups. Tissue sections of the first group
were frozen immediately in liquid nitrogen and later used
for standard PCR. Those of the second group were fixed in
4% PFA in phosphate buffered saline (PBS) at room
temperature overnight and embedded in paraffin. Sections
(5-µm-thick) were prepared and then mounted on 3-
aminopropyltriethoxysilane-coated glass slides and used for
in situ PCR.
PCR method
Genomic DNA was prepared from the testis or ovary of
ICR mouse with AquaPure Genomic DNA Kits (Bio-Rad,
Richmond, CA) according to the instruction manual provid-
ed by the manufacturer. When the PCR conditions were
optimized, the band intensity corresponding to the increased
amount of DNA correlated linearly with the PCR cycle
number. The bands were quantitated by densitometry (NIH
Image J software, version 1.08i, http://rsb.info.nih.gov/ij/)
and each value was expressed relative to that of mouse
glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Primers (BEX Co., Japan) corresponding to mouse pgk1
were 5'-CACGCTTCAAAAGCGCACGTCT-3' and 5'-
CTTGAGGGCAGCAGTACGGAAT-3', while those for
mouse GAPDH were 5'-ACCACAGTCCATGCCATCAC-3'
and 5'-TCCACCACCCTGTTGCTGTA-3'. The Gene Amp
PCR System 9400 (PE Applied Biosystems, Foster City,
CA) was used for gene amplification. PCR was carried out
in a 20-µl final volume of reaction mixture, containing 0.5
units of TaKaRa ExTaq polymerase, 0.2 mM of each dNTP,
ExTaq buffer (1×), 1 µM of each specific primer described
above and 100 ng of testis or ovary DNA as a template. Each
cycle of PCR included 20 sec of denaturation at 94°C, 20 sec
of annealing at 55°C, and 30 sec of extension at 72°C. After
28 reaction cycles, the PCR products were separated on a
1.5% TAE-agarose gel and stained with ethidium bromide.
The amplified PCR products with pgk-1 primers were
loaded onto a 3% agarose gel, and the DNA bands of the
predicted size were cut, purified with glass powder and in-
tegrated into pGEM-easy (Promega, Madison, WI). BigDye
terminator cycle sequencing was performed against the
pgk-1 plasmid and the sequence was determined with ABI
PRISM 310 Genetic Analyzer (PE Applied Biosystems)
using the instructions provided by the supplier.
In situ PCR method
The oligo-DNAs that can amplify part (170 bp) of
the mouse X chromosome-linked pgk-1gene were used as
primers as described above. The tissue sections were
deparaffinized and rehydrated using standard procedures.
These sections were digested with 0–100 µg/ml of PK
(37°C, 15 min). After post-fixation with 4% PFA in PBS
(5 min), the sections were washed in PBS and immersed in
50% formamide in 2×SSC (1×SSC=0.15 M sodium chloride
and 0.015 M sodium citrate, pH 7.0) overnight at 4°C. After
washing with double-distilled water (DDW, 5 min, 3 times),
the sections were completely desiccated. For each slide, the
amplification mixture was prepared in a final volume of 100
µl, containing 1×PCR buffer, 1.0 µg/ml forward primer, 1.0
µg/ml reverse primer, 0.2 mM dNTP, 2.5 mM MgCl2, and
2.5 U/100 µl Taq DNA polymerase. To label the amplified
DNA, 5.0 µM Dig, 2.0 µM Cy-3, and 0.2 µM FluorX
were used. The slides were sealed with EasiSeal (Hybaid,
UK), and then placed on the heated plate of the OmniSlide
System (Hybaid); the DNA in the tissues then was denatured
at 94°C for 3 min. As for PCR cycle studies, 5, 10, 15, 20,
25, or 30 cycles of amplification (denaturation for 15 sec at
94°C, annealing for 15 sec at 56°C, extension for 60 sec at
72°C) were run. The slides were then heated at 72°C for 5
min. After amplification, the cover slips were removed and
the slides were washed with 2×SSC (37°C, 15 min, 4 times).
As a negative control, in situ PCR was performed with the
omission of Taq DNA polymerase and the primers.
Visualization and image analysis
The Dig-labeled signals were detected by enzyme
immunohistochemistry, and the images of the Dig-labeled
sections were analyzed using an Olympus BH-2 microscope
connected to a Canon CCD camera, and an Olympus SP-500
Image analyzer with Image Command program 5098 as
described in detail previously [26]. Cy-3 and FluorX signalsOptimization of In Situ PCR 17
were detected using a Zeiss fluorescence microscope
connected to a CCD camera (AxioCam, Carl Zeiss, Jena,
Germany).
Statistical analysis
All data were expressed as mean±SD. Differences
between groups were examined for statistical significance
using the unpaired Student’s t-test. A P value less than 0.05
denoted the presence of a statistically significant difference.
All analyses were performed with a statistical software
package (StatView, version 5.0; Abacus Concepts, Berkeley,
CA).
III. Results
PCR products
PCR products comprising 170 bp were obtained
(Fig. 1) and were confirmed by DNA sequencing to be part
of the pgk-1 gene. Semiquantitative analysis of these
products using the NIH Image analysis system showed that
the quantity of the pgk-1 gene product from the ovary was
about 2-fold more than that from the testis.
PK concentration
The effect of digestion by PK at concentrations from
0 to 100 µg/ml was evaluated using FluorX. The optimal
concentration of PK, as evaluated by the signal-to-noise
ratio, was 50 µg/ml for the ovary (Fig. 2). One to 4 pgk-1
spots were detected in the nuclei of granulosa cells
Fig. 2. Effects of various concentrations of PK in mouse ovary using FluorX. Upper panels (A, B, C) were carried out Taq polymerase and lower
panels (D, E, F) were performed omitting Taq polymerase. PK was evaluated at varying concentrations from 5 µg/ml (A, D), 20 µg/ml (B, E),
and 50 µg/ml (C, F). One to 4 green spots were detected in the nuclei of granulosa cells (C). Red arrow; 4 spots. Yellow arrows; 3 spots. White
arrows; 2 spots. Bar=20 µm.
Fig. 1. PCR of pgk-1 gene in mouse ovary and testis. PCR products
of pgk-1 (170 bp) were found in mouse ovary and testis.Hishikawa et al. 18
(Fig. 2C). Treatment of the sections with 100 µg/ml PK
resulted in diffuse spreading of the signal (data not shown).
There was no difference between the use of FluorX and
Cy-3 dye for in situ PCR.
PCR cycle
The effect of different PCR cycles (from 5 to 30 cycles)
was evaluated using FluorX, Cy-3 and Dig dyes. For
FluorX, 25 cycles were optimal for the detection of the
pgk-1 gene in the nuclei of granulosa cells (Fig. 3C). Ten
cycles was the optimum number of PCR cycles necessary to
detect pgk-1 gene in the nuclei of ovarian granulosa cells
using Dig (Fig. 4A). The signal-to-noise ratio of FluorX and
Cy-3 for granulosa cells was better than that of Dig (Fig. 3C
and Fig. 4A). Amplification over 10 cycles for Dig or over
25 cycles for Cy-3 and FluorX significantly increased the
background signals due to the diffusion of PCR products
into the surrounding tissues (Fig. 3D). For the testis, the
concentration of PK was 10 µg/ml and 25 cycles of PCR was
optimal, and 1–2 spots were detected in the nuclei of some
germ cells using Cy-3 dye (Fig. 5A). Testicular sections
treated with 20 µg/ml PK showed no signal for pgk-1 gene
(data not shown).
Number of pgk-1-positive spots in mouse granulosa cells
Finally, we determined the percentage of granulosa
cells containing one or more pgk-1-positive spots after
employing 15 cycles and 25 cycles. Five tissue samples were
used in these experiments. The number of pgk-1-positive
spots in granulosa cells was 1.6±0.1 spots/cell in the ovary
using 15 cycles for in situ PCR and 2.5±0.1 spots/cell using
25 cycles (P<0.0001) (Fig. 6A). The percentage of pgk-1-
positive granulosa cells after using 25 cycles for in situ PCR
was as follows: 15.8±5.8% of the cells showed 1 spot in the
nuclei, 37.2±7.1% of the granulosa cells showed 2 spots,
18.7±8.3% of the cells had 3 spots, and 27.7±4.5% had 4
spots (Fig. 6B).
IV. Discussion
In the present study, we assessed the utility of in situ
PCR in detecting a specific gene using paraffin-embedded
sections of mouse reproductive organs. Using in situ PCR,
we found 1 to 4 pgk-1 spots in the nuclei of granulosa cells
and 1 to 2 pgk-1 spots in the nuclei of the germ cells under
optimal number of PCR cycles and PK concentration.
In practice, in situ PCR is technically difficult, and
there is no standard protocol for optimal detection, especially
Fig. 3. Effects of different PCR cycles
in mouse ovary using FluorX. Five
cycles (A), 15 cycles (B), 25 cycles
(C), and 30 cycles (D) of PCR were
performed using Taq polymerase.
One to 4 green spots were detected in
the nuclei of granulosa cells (C). As a
negative control, 25 cycles of PCR
were performed omitting Taq poly-
merase (E). Red arrows; 4 spots.
Yellow arrows; 3 spots. White arrows;
2 spots. Bar=20 µm.Optimization of In Situ PCR 19
when using paraffin-embedded tissue sections. We were
able to detect 1 to 4 spots of pgk-1 in granulosa cells using
our optimal conditions. However, when the PCR cycles
were increased to more than 25 cycles for Cy-3 and FluorX,
the signals were diffusely spread in the sections. In fact,
the diffusion of the amplified products from the target cells
is a major problem in this method [11, 25]. The factors that
influence diffusion include excessive protease digestion
Fig. 4. Detection of pgk-1 in mouse ovary using Dig. One to 2 red spots were detected in the nuclei of granulosa cells using image analysis
system (A). PCR cycles were 10 times, and PK concentration was 50 µg/ml. Taq polymerase was omitted as a negative control (B). Bar=20 µm.
Fig. 5. Detection of pgk-1 in mouse testis using Cy-3. One to 2 red spots of Pgk-1 gene were detected in the nuclei of germ cells with 10 µg/ml
PK concentration and 25 cycles (A). Yellow arrow; 2 spots. White arrows; 1 spot. Taq polymerase was omitted as a negative control (B).
Bar=20 µm.
Fig. 6. Pgk-1-positive spots in mouse granulosa cells. The number of pgk-1-positive spots after employing 15 cycles and 25 cycles (A). The
percentage of pgk-1-positive granulosa cells after using 25 cycles for in situ PCR (B). Data represent mean±SD. *P<0.0001.Hishikawa et al. 20
[5, 18] and the use of an excessive number of PCR amplifi-
cation cycles [5, 11, 21, 27]. In relation to the diffusion of
the PCR products into the surrounding tissue, non-specific
incorporation of labeled nucleotides into fragmented DNA,
and the inhibitory effects of cross-linking of histones to
DNA or PCR amplification are problematic. Long et al. [13]
reported some false positive results, especially when using
tissue sections, which were related to non-specific incorpo-
ration of labeled nucleotides into cellular DNA through
internal priming and DNA repair. This was due, at least in
part, to the exonuclease activity of Taq DNA polymerase. In
our experiments, however, the diffusion of PCR products
could be minimized by reducing the number of PCR cycles
and the use of appropriate concentrations of PK.
Recently,  in situ reverse transcription-PCR (in situ
RT-PCR) has been used to detect low levels of mRNA
within cells and tissue sections [2, 14, 15, 20, 23]. However,
this method has certain limitations in detecting specific
mRNAs. This is because detection of very few copies of
mRNA in tissues or cells by this method requires the PCR
reaction to be performed after carrying out reverse transcrip-
tion of the specific mRNA to cDNA using reverse tran-
scriptase. Then, it is necessary to determine whether this
reaction truly occurs within the individual cell. Moreover, it
is also important to establish that the RT-PCR reaction is of
genomic DNA origin, and that the products truly originated
from the target mRNA. For these reasons, we considered the
in situ RT-PCR method to be unsuitable for evaluating the
experimental results obtained by the in situ PCR method.
For in situ PCR, two main protocols, direct and indirect
in situ PCR, have been described [11, 13, 25]. In the direct
detection approach, the labeled nucleotides are directly
incorporated into the PCR products, while the indirect
method consists of an initial PCR reaction without labeled
nucleotides, followed by in situ hybridization using labeled
probes to the PCR products. The direct in situ PCR has been
reported to increase the turn-around time and ease of in situ
PCR studies due to hot-start modifications of in situ PCR
without jeopardizing specificity [19].
In conclusion, in situ PCR is a potentially useful
method for detecting a specific gene at cellular and sub-
cellular levels, and may prove suitable for evaluation of the
functional organization of various genes in paraffin tissue
sections when used with critical PK concentration and PCR
cycle number.
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